Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
5
self-reported band not used
Founded
2021
5 years
Legal entities
1
ACRA
Office countries
3
3 addresses
Funding rounds
1
Seed · May 2022
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
M20 GENOMICS PTE. LTD.Entity record →
UEN202324304H
Legal entities
Show as table · M20 Genomics: 1 registry entity
| M20 GENOMICS PTE. LTD. | UEN 202324304H |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
We are a rapidly growing life science technology company dedicated to pushing the boundaries of single-cell and spatial technologies. Our mission is to empower our customers by overcoming technological barriers in cutting-edge single-cell and spatial technologies, unraveling mysteries in life science, and driving advancements in disease diagnosis and treatment.
With "M20 Seq" technology, we have pioneered the world's first high-throughput full-length single-cell technology sequencing using random primers, along with our VITA product line for single-cell transcriptome sequencing. In addition, our "M20 Spatial" technology, utilizing random primers and paired with our NATA spatial transcriptome product line, provides the first spatial full-transcriptome solution across various sample types.
Locations
3
Countries with an office address3 addresses on record
Country footprint
Show as table · Offices in 3 countries
| Countries | 3 |
|---|---|
| Primary country | SG |
All codes: SG CN US
Addresses
- SG6 Raffles Quay; #14-02; Singapore, 048580Primary
- US2626 Glenwood Ave; Suite 550; Raleigh, NC 27608
- CNBuilding 2, Tianchuang Tech Park 26 Longquan Road; Hangzhou, Zhejiang 310000
Grid intelligence Members
Funding
Rounds1
Round typeSeed · venture round
Amount (USD)not recorded
Stage rank2
Investors named1
Since last round3 yr 8 mo
Funding
Show as table · 1 funding round
| Rounds | 1 |
|---|---|
| Axis | 2021 to 2026 |
| Seed · 21 May 2022 | not disclosed |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
2 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under M20 Genomics?
One Singapore entity on ACRA: M20 GENOMICS PTE. LTD. (UEN 202324304H), high confidence.
How many people work at M20 Genomics?
5 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Where does M20 Genomics have offices?
Three addresses on record across 3 countries. Primary: 6 Raffles Quay, #14-02, Singapore 048580.
Has M20 Genomics raised funding?
One round. Latest 21 May 2022: Seed, investor Qiming Venture Partners, no amount recorded.
Which companies are listed alongside M20 Genomics?
2 profiles list M20 Genomics as a peer — 42nd percentile in Biotechnology Research. It lists ten peers of its own. Mindd Health lists it back.